Therefore, there is no guaranty that any payment will be made to holders of CVRs in respect of their contingent value rights
The merger includes contingent value rights
for existing Gemphire stockholders entitling them to receive certain cash payments in the event the gemcabene assets are sold or licensed during the CVR period.
In addition, IAM shareholders will receive contingent consideration from Fiera Capital in the form of contingent value rights
tied to a portion of certain incentive fees that may be received in the future from two real estate funds managed by IAM affiliates, as further described below.
The case arose when Twin River announced its intentions to pay its post-bankruptcy holders of "contingent value rights
" a fair value for their shares before those rights expired.
The latest offer is for EUR30.50 per share in cash, which includes a EUR2.50 per share in contingent value rights
(CVR), while the first offer made in early December was EUR26.75 per share.
In addition to the upfront cash payment, Alexza stockholders will be granted contingent value rights
to receive cash payments in four payment categories if specified milestones are achieved following the closing.
In addition the offer included a USD40m dividend to AuthenTec stockholders plus contingent value rights
allowing them to obtain further shares in the combined company if its common stock trades below a certain level.
ACLARA stockholders will own around 48% of the company and have contingent value rights
for potential cash payments.
As a consequence of the forthcoming termination of the Collaboration Agreement, and in accordance with the terms and conditions of the Contingent Value Rights
Agreement, dated April 23, 2019, by and among Mereo and Computershare Inc., as rights agent, it is not expected that holders of contingent value rights
pursuant to the CVR Agreement will be entitled to receive the TIGIT Milestone Payment.
The transaction also covers contingent value rights
giving right to shares for an additional value of up to $55 million, based on the potential US Food and Drug Administration (FDA) approval(s) of AC-170 and two additional undisclosed products within a pre-determined period.
(NYSE: MSL) has reported that the contingent value rights
(CVRs) issued by MidSouth as part of the consideration for the acquisition of PSB Financial Corp have matured and MidSouth will be making the maximum payment to the CVR holders on or about April 20, 2013.
In conjunction, about USD42.5m in cash will be paid, approximately 7.0m shares of Wright common stock and 28.1m contingent value rights
(CVRs) will be issued.